INTERNATIONAL FEDERATION OF CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR MEASUREMENTS OF APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B .4. COMPARABILITY OF APOLIPOPROTEIN-B VALUES BY USE OF INTERNATIONAL REFERENCE MATERIAL

被引:0
作者
MARCOVINA, SM
ALBERS, JJ
KENNEDY, H
MEI, JV
HENDERSON, LO
HANNON, WH
机构
[1] NATL CTR ENVIRONM HLTH,DIV ENVIRONM HLTH LAB SCI,ATLANTA,GA
[2] CTR DIS CONTROL & PREVENT,ATLANTA,GA
关键词
IMMUNOASSAYS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We performed temporal and thermal stability studies on SP3-07, a liquid-stabilized reference material for apolipoprotein (ape) B, selected during the previous phase of the International Federation of Clinical Chemistry project on standardization of apolipoprotein measurements. Results indicate that SP3-07 stored at -70 degrees C has the long-term stability required for a reference material. We assigned an accuracy-based apo B value of 1.22 g/L to SP3-07, using a nephelometric method that was calibrated with freshly isolated low-density lipoprotein for which the apo B mass value was determined by a standardized sodium dodecyl sulfate-Lowry procedure. Using a common protocol, the study participants transferred the assigned mass value from SP3-07 to the individual calibrators of the analytical systems and measured the ape B concentration of 20 fresh-frozen samples obtained from individual donors and covering a clinically relevant range of apo B values. The among-laboratory CV on these samples, analyzed by 25 analytical systems, ranged from 3.1% to 6.7%. These results demonstrate the lack of matrix effects of SP3-07 and its ability to provide accurate and comparable apo B values in a variety of immunochemical methods. On the basis of the outcome of these studies, the World Health Organization has endorsed SP3-07 as the International Reference Material for Apolipoprotein B.
引用
收藏
页码:586 / 592
页数:7
相关论文
共 20 条
[1]  
ALBERS JJ, 1989, J LIPID RES, V30, P1445
[2]  
ALBERS JJ, 1992, CLIN CHEM, V38, P658
[3]  
ALBERS JJ, 1992, PLASMA LIPOPROTEINS, P265
[4]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[5]  
COOPER GR, 1985, CLIN CHEM, V31, P223
[6]  
FINK PC, 1989, J CLIN CHEM CLIN BIO, V27, P261
[7]  
KENNEDY JW, 1986, NCCLS, V6, P1
[8]  
Kimberly Mary M., 1993, Clinical Chemistry, V39, P1123
[9]  
MARCOVINA SM, 1989, CLIN CHEM, V35, P2009
[10]  
MARCOVINA SM, 1991, CLIN CHEM, V37, P1676